Takaoka, Japan

Junko Yasuda


Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junko Yasuda: Innovator in Nucleic Acid Transfection and Metalloproteinase Inhibitors

Introduction

Junko Yasuda is a prominent inventor based in Takaoka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of compositions for nucleic acid transfection and metalloproteinase inhibitors. With a total of two patents to her name, Yasuda's work has the potential to impact various applications in medical and biological research.

Latest Patents

Yasuda's latest patents include a composition for nucleic acid transfection. This invention provides a nucleic-acid-transfecting composition that exhibits low cytotoxicity, facilitating effective nucleic acid transfection into cells and improving expression within those cells. The composition contains a di(Calkyl)dimethylammonium halide and a phospholipid, showcasing her innovative approach to enhancing transfection efficiency. Additionally, she has developed highly water-soluble metalloproteinase inhibitors, which are crucial for various therapeutic applications.

Career Highlights

Throughout her career, Junko Yasuda has worked with notable companies, including Fuji Yakuhin Kogyo Kabushiki Kaisha and Hokkaido System Science Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Yasuda has collaborated with esteemed colleagues such as Tetsunori Fujisawa and Shinjiro Odake. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Junko Yasuda's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in nucleic acid transfection and metalloproteinase inhibitors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…